RadNet, Inc. (RDNT) vs Twist Bioscience Corporation (TWST)

RadNet, Inc. and Twist Bioscience Corporation are both Diagnostics & Research companies. Twist Bioscience Corporation is the larger, with a market value of $9.5B against $5.5B — 1.7× the size. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against 18.9%. RadNet, Inc. has the higher net margin (−0.93% vs −31.7%) and the higher return on invested capital (2.24% vs −30.8%). Across the 18 metrics below, RadNet, Inc. leads on 12 and Twist Bioscience Corporation on 6.

Valuation

Metric RDNT TWST Diagnostics & Research median
P/E n/m n/m 35.56
P/S 2.35 19.18 4.37
P/B 3.82 18.58 3.06
Price to free cash flow 164.99 n/m 35.76
EV/EBITDA 19.29 n/m 24.35
EV/Sales 2.62 18.84 5.51
Earnings yield (0.39%) (1.67%) (1.89%)
Free cash flow yield 0.61% (1.15%) (0.15%)

Profitability

Metric RDNT TWST Diagnostics & Research median
Gross margin 11.53% 51.97% 50.89%
Operating margin 3.12% (33.58%) (8.57%)
Net margin (0.93%) (31.66%) (6.37%)
Free cash flow margin 3.28% (22.15%) 0.00%
Return on equity (1.64%) (29.59%) (2.92%)
Return on assets (0.55%) (20.78%) (6.71%)
Return on invested capital 2.24% (30.83%) 0.00%

Growth

Metric RDNT TWST Diagnostics & Research median
Revenue growth (TTM) 18.92% 19.19% 7.69%
EPS growth (last fiscal year) (725.00%) 63.89% 25.92%
Revenue growth, 5-year CAGR 13.74% 33.11% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RDNT TWST Diagnostics & Research median
Debt to equity 0.94 0.03 0.11
Current ratio 1.48 2.67 2.02
Net debt to EBITDA 1.16 1.95 0.70

Dividend

Metric RDNT TWST Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric RDNT TWST Diagnostics & Research median
Market cap 5.54b 9.51b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack